Samuel Whiting - 11 Oct 2023 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Stephen Brady, Attorney-in-Fact
Issuer symbol
TPST
Transactions as of
11 Oct 2023
Net transactions value
$0
Form type
4
Filing time
13 Oct 2023, 16:39:13 UTC
Previous filing
05 Jan 2023
Next filing
05 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +325,000 $0.000000 325,000 11 Oct 2023 Common Stock 325,000 $9.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the award shall vest on October 11, 2024 and the remainder of the award shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.